Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon

Menu

Search BMS Clinical Trials
BMS Recruiting Study icon

Recruiting

Trial ID CN013-0002  |   NCT07772531

A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder

Summary

  • Phase 2
  • Male and Female Gender icon
  • 18-65
    Age Range
  • 26
    Locations
  • BMS Recruiting Study icon
    Recruiting

Overview

A Study to Evaluate BMS-986511 in Adults with Major Depressive Disorder

Nearest Recruiting Site

Key Eligibility Criteria

Inclusion Criteria

Inclusion Criteria Icon img
:
  • Participants must meet the MDD diagnosis per DSM-5 criteria confirmed by structured interview.
    1. Participant must have current moderate to severe MDE confirmed by clinical assessment and validated scale.
      1. Participant must have current MDE duration >12 weeks at screening.
        1. Outpatient participants able to comply with study procedures.
          1. Participant require medication washout completed before baseline.
            1. Participant must have BMI within protocol range.
              1. Participants must meet reproductive safety requirements.

                Exclusion Criteria

                Exclusion Criteria Icon
                :
                • Participants must not have other primary psychiatric disorders or a history of treatment-resistant depression during the current episode.
                  1. Participants must not have recent history of active suicidal ideation or attempt within the past year.
                    1. Participants must not have prior lifetime treatment with electroconvulsive therapy, ketamine/esketamine, deep brain stimulation, or transcranial magnetic stimulation.
                      1. Participants must not have recent history of alcohol/substance abuse or use of cannabis.
                        1. Participants must not have significant ECG abnormalities, or poorly controlled diabetes.
                          1. Other protocol defined inclusion/exclusion criteria apply.
                            Additional Information *

                            Treatment Options

                            Study Arms

                            ASSIGNED INTERVENTION

                            Study Arms

                            Experimental: BMS-986511: Dose A

                            ASSIGNED INTERVENTION
                            • Drug: BMS-986511

                            Study Arms

                            Experimental: BMS-986511: Dose B

                            ASSIGNED INTERVENTION
                            • Drug: BMS-986511

                            Study Arms

                            Experimental: Placebo

                            ASSIGNED INTERVENTION
                            • Drug: Placebo
                            Take the first step to see if you Match to a Clinical Trial – Check Your Eligibility
                            Check Your Eligibility
                            Answer some questions about Your health to see if you may match to this trial
                            Match to a Trial
                            If you are a match, click on the study to see the list of study site locations
                            Select a Study Site Location
                            Select a study site location that is convenient for you
                            Register
                            Provide your contact details for the study site to connect with you.

                            Help us enhance your website experience! Share your feedback with our team at BMS Clinical Trials to improve yours and others’ experience. Thank you

                            Help us enhance your website experience! Share your feedback with our team at BMS Clinical Trials to improve yours and others’ experience. Thank you